News
Drugmaker Merck reports quarterly results Thursday morning as fears grow over the expiration of the patent on its top-selling ...
Merck, Black Hills, and Virtus Investment Partners are good choices for investors seeking reliable passive income. Their ...
We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...
Last year Merck agreed a similar licensing deal, also worth $2 billion, for Chinese biotech Hansoh Pharma’s experimental oral obesity drug, while yesterday Denmark’s Novo Nordisk (NVO ...
Merck, Black Hills, and Virtus Investment Partners have rewarded ... Merck (NYSE:MRK) is a healthcare company that manufactures pharmaceutical products to treat various conditions in many therapeutic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results